Legislature(2021 - 2022)ADAMS 519
03/31/2022 09:00 AM House FINANCE
Note: the audio ![]()
and video ![]()
recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
| Audio | Topic |
|---|---|
| Start | |
| HB306 | |
| HB60 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| += | HB 306 | TELECONFERENCED | |
| + | HB 170 | TELECONFERENCED | |
| + | TELECONFERENCED | ||
| += | HB 60 | TELECONFERENCED | |
HOUSE BILL NO. 306
"An Act extending the termination date of the Board of
Pharmacy; and providing for an effective date."
9:08:55 AM
REPRESENTATIVE ANDI STORY, SPONSOR, thanked the committee
for hearing the bill. She stated that the Board of Pharmacy
must be extended for the critical work of licensing and
regulation of the profession. She agreed with the auditor's
recommendation of extending the board for six years. She
remarked that legislators all shared a concern about the
Prescription Drug Monitoring Program (PDMP). She believed
fixing the PDMP was a separate issue from the extension of
the board. She clarified that the PDMP was housed under the
Board of Pharmacy; however, the board only had enforcement
power and regulatory oversight over pharmacists. She
highlighted that the Medical Board, Board of Nursing, Board
of Dental Examiners, Board of Examiners and Optometry, and
Board of Veterinarian Examiners all participated in the
PDMP. She relayed that the chairs of the boards met twice a
month solely about the PDMP. She shared that her staff had
been working closely with the Department of Commerce,
Community and Economic Development (DCCED) and Sara
Chambers [Director, Division of Corporations, Business and
Professional Licensing, DCCED] and they all felt strongly
about how to make some progress in the PDMP. She requested
to hear from Ms. Chambers.
9:11:10 AM
AT EASE
9:11:37 AM
RECONVENED
SARA CHAMBERS, DIRECTOR, DIVISION OF CORPORATIONS, BUSINESS
AND PROFESSIONAL LICENSING, DEPARTMENT OF COMMERCE,
COMMUNITY AND ECONOMIC DEVELOPMENT, appreciated the
members' desire for a solution to ensure the PDMP was doing
what the legislature had set forth for the program to do
and to ensure it was doing it well. In addition to that,
everyone understood and agreed on the expectations of the
PDMP. She appreciated the bill sponsor's desire to find
some solutions. She communicated that since the last bill
hearing, the department had been working with the board
chairs and some members of the House Finance Committee to
identify existing funding sources that could help the
department locate a contractor, consultant, or individual
with PDMP expertise who could take a holistic view of how
the PDMP fit into the state's opioid crisis management.
Additionally, the individual could help determine whether
legislation could be recommended in a subsequent report to
the legislature to address changes ranging from small to
large, what the department, boards, and administration
could be doing differently, looking at other states, and
providing technical assistance.
Ms. Chambers stated the resources were out there and they
were working to connect the dots, especially with the
department's limited resources. She elaborated that they
had been working with the Division of Public Health to
identify some grant funding. They believed it may provide
an option to move forward on a report and analysis in a way
that would edify the concerns.
9:13:52 AM
Representative Edgmon relayed that he had been one to raise
concerns about the PDMP. He appreciated the information,
and it satisfied his concern. He was ready to support the
legislation.
Representative LeBon MOVED to ADOPT Amendment 1, 32-
LS1434\A.2 (Ambrose, 3/16/22) [by Representative Carpenter]
(copy on file):
Page 1, line 5
Delete "2028"
Insert "2026"
Representative Edgmon OBJECTED.
Representative LeBon explained the amendment. He stated
that the committee had heard from the legislative auditor
there were some issues with board governance and the
working relationship between the Board of Pharmacy and the
agency. He thought the legislature would want to see
progress towards improving the work of the board. He
supported a reduction in the extension of the board from
2028 to 2026.
Representative Edgmon MAINTAINED his OBJECTION.
A roll call vote was taken on the motion.
IN FAVOR: Johnson, Josephson, LeBon, Thompson
OPPOSED: Ortiz, Wool, Edgmon, Merrick, Foster
The MOTION to adopt Amendment 1 FAILED (4/5).
9:15:58 AM
AT EASE
9:16:08 AM
RECONVENED
Vice-Chair Ortiz MOVED to REPORT HB 306 out of committee
with individual recommendations and the accompanying fiscal
note.
Representative Johnson OBJECTED for discussion. She
remarked that she put a reminder in her calendar to bring
up the topic the following session. She wanted to ensure
the legislature was doing its do diligence. She had some
concerns about the length [of the board extension] because
some issues had been identified. She remarked that going
forward with the next year's budget, it was easy to let
things go by the wayside. She remarked there may be an
opportunity in the future to talk about boards and
commissions, which she believed would likely be healthy for
some of the state's boards. She was not interested in
shutting the board down or in spending a substantial amount
of money on another audit to come back to the committee to
report that the same thing was still happening. She stated
that somehow the legislature needed to figure out how to
get a report that may not be 100 percent or exactly what
the legislature wanted to vote on. The legislature would
need to determine how to deal with it.
Representative Johnson WITHDREW her OBJECTION.
There being NO further OBJECTION, HB 306 was REPORTED out
of committee with three "do pass" recommendations and six
"no recommendation" recommendations and with one previously
published fiscal impact note: FN1 (CED).
9:17:59 AM
AT EASE
9:20:02 AM
RECONVENED